Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [Research] Celltrion (068270) – Shinhan Securities | New Product Sales Expansion · Operating Leverage · Global CMO Contracts / 2026-05-15 Research
  • [Research] Hanwha Ocean (042660) – Daishin | Early Offshore Revenue · Naval Defense Pipeline · Excessive Discount / 2026-07-09 Research
  • [Research] SK hynix (000660 / SKHY) – iM Securities | DRAM Pricing · ADR Listing · Multiple Recovery / 2026-04-24 Research
  • [IR] SK hynix (000660 / SKHY) – Q1 2025 Earnings Presentation / 2025-04-24 IR Room
  • [Research] Alteogen (196170) – Hana Securities | GSK Single-Asset Deal Analysis · Expanding SC Competitiveness · Ongoing 2026 Deal Catalysts / 2026-01-21 Research
  • [Research] Alteogen (196170) – Shinhan Securities | 2 Out-Licensing Deals in Q1 · Biogen Deal Analysis · Major Catalysts Ahead from April / 2026-03-27 Research
  • [Research] Celltrion (068270) – SK Securities | 2Q26 Re: Profitability Inflection Underway · Operating Leverage In Focus · Robust H2 Momentum / 2026-08-03 Research
  • [Research] Samsung Electro-Mechanics (009150) – IBK Securities | MLCC Price Hike · Supply Shortage · Earnings Acceleration / 2026-07-31 Research

[Research] SK hynix (000660 / SKHY) – Shinhan | Memory Pricing · LTA · Supplier Pricing Power / 2026-04-06

Posted on April 6, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : Shinhan Investment Corp.

Analyst : Hyungtae Kim, Hyesu Song

Investment Rating : BUY (Maintained)

Target Price : 1,500,000 KRW (Upgraded)

Core Momentum : Sustained DRAM and NAND price increases amid constrained supply are expected to drive record profitability, while expanding LTAs strengthen supplier pricing power and extend earnings visibility in an excess-demand environment.

📊 1. [Valuation & Key Financial Metrics]

  • Target Price / Investment Rating: 1,500,000 KRW (Upgraded) / BUY (Maintained)
  • Current Price (as of April 3): 876,000 KRW (Upside potential: 71.2%)
  • Market Capitalization: 624,327.3 billion KRW (Free float ratio: 75.2%)
  • Key Financial Metrics (2024 / 2025 / 2026F / 2027F / 2028F):
    • Revenue: 66,193.0 billion KRW / 97,146.7 billion KRW / 274,996.1 billion KRW / 374,245.4 billion KRW / 434,732.0 billion KRW
    • Operating Profit: 23,467.3 billion KRW / 47,206.3 billion KRW / 201,864.2 billion KRW / 277,895.9 billion KRW / 295,008.0 billion KRW
    • Net Income Attributable to Controlling Interests: 19,788.7 billion KRW / 42,919.3 billion KRW / 176,858.1 billion KRW / 231,984.8 billion KRW / 245,830.5 billion KRW
    • PER: 6.4x / 11.0x / 3.5x / 2.7x / 2.5x
    • PBR: 1.7x / 3.9x / 2.1x / 1.2x / 0.8x
    • ROE: 31.1% / 44.2% / 85.0% / 56.5% / 38.0%
    • EV/EBITDA: 3.9x / 7.7x / 2.5x / 1.3x / 0.6x
    • DY: 1.3% / 0.5% / 0.5% / 0.5% / 0.5%

🚀 2. [Market Opportunities & Business Outlook]

  • 1Q26 Preview: Revenue is projected at 50.4 trillion KRW (+53.5% QoQ) and operating profit at 35.5 trillion KRW (+85.1% QoQ), outperforming market consensus (46.6 trillion KRW, 31.6 trillion KRW). Divisional operating profit is expected to reach 29 trillion KRW for DRAM and 6.6 trillion KRW for NAND. Bit growth (B/G) is estimated at +0.2% for DRAM and -11.1% for NAND, while ASPs are estimated to rise by +49% and +61% respectively. Accelerated ASP growth in legacy products is expected to yield operating margins of 76% for DRAM and 56% for NAND.
  • Full-Year Earnings Outlook: Full-year revenue is estimated at 275 trillion KRW (+183.1% YoY) and operating profit at 201.9 trillion KRW (+327.6% YoY), with operating profit margins for DRAM and NAND projected to set new record highs at 78.9% and 58.6% respectively.
  • Supply-Demand Environment and LTAs: Limited bit growth (B/G) is expected to persist through year-end amid excess demand. As major big-tech clients materialize long-term agreement (LTA) proposals, pricing power is shifting heavily toward suppliers, potentially extending SK hynix’s leadership in HBM3E longer than anticipated.
  • Mid-to-Long-Term Catalysts: Additional catalysts include a U.S. ADR listing in the second half, portfolio diversification into high-value applications (HBM4, So-CAMM, V9 NAND), and a revival of market leadership as macroeconomic uncertainties ease.

📝 Editor’s Comment (Perspective)

The analyst evaluates that as price uptrends across all DRAM and NAND products exceed expectations, the proliferation of long-term agreements (LTAs) and constrained shipment growth are strengthening supplier pricing power, driving projected annual operating profits beyond 200 trillion KRW. This perspective places greater emphasis on accelerated profitability and earnings visibility within an excess demand environment rather than short-term market fluctuations.

To determine whether this investment thesis is unfolding as projected, key items to monitor include the delivery of the projected 35.5 trillion KRW operating profit for Q1, the realization of full-year operating profit guidance of 201.9 trillion KRW, the preservation of supplier pricing power through LTAs, and the execution of the second-half ADR listing and product diversification schedules. These developments can be tracked through upcoming quarterly and annual earnings releases, official corporate IR materials, and regulatory disclosures via DART/KRX.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] SK hynix (000660 / SKHY) – Hana | Memory Pricing · Earnings Upgrades · LTA / 2026-04-02
Next Post: [Research] SK hynix (000660 / SKHY) – Mirae Asset | Multi-Year LTA · Price Downside Protection · ROE Sustainability / 2026-04-06

Related Posts

  • [Research] SK hynix (000660 / SKHY) – Kyobo | Agentic AI · High-Value Memory · Pricing Momentum / 2026-04-24 Research
  • [Research] Samsung Biologics (207940) – iM Securities | New Plant Operations · PolyPeptide Acquisition · Portfolio Diversification / 2026-07-24 Research
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · Server Demand · Earnings Upgrades / 2026-01-30 Research
  • [Research] Hanwha Ocean (042660) – Hanwha | Merchant Margin Surprise · High-Price Mix Expansion · Special Ship Fixed-Cost Absorption / 2026-04-28 Research
  • [Research] Celltrion (068270) – iM Securities | New Product Mix Expansion · First-Mover Advantage · Two-Track Long-Term Strategy / 2026-07-28 Research
  • [Research] LIG D&A (079550) – Hanwha Investment & Securities | 4Q25 Review · Ghost Robotics Impairment Cleared · Margin Expansion / 2026-02-23 Research
  • [IR] SK hynix (000660 / SKHY) – Q4 2023 Earnings Presentation / 2024-01-25 IR Room
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Hyperscaler Capex · Custom HBM · Inference Memory Demand / 2026-05-04 Research
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | AI MLCC Shortage · FC-BGA Margin Expansion · Earnings Direction / 2026-07-31 Research
  • [Research] LIG D&A (079550) – Kiwoom Securities | Supply Shortage vs Rising Demand · Middle East Backlog · Haegung Expansion / 2026-04-30 Research
  • [Research] Samsung Biologics (207940) – iM Securities | Annual Operating Profit Surpasses KRW 2T · Pure-CDMO Transition · Three-Pillar Growth Strategy / 2026-01-22 Research
  • [IR] Samsung Electro-Mechanics (009150) – Q2 2026 Earnings Presentation / 2026-07-30 IR Room
  • [Research] Samsung SDI (006400) – Kiwoom Securities | ESS & BBU Momentum · Europe Market Share Recovery · 4Q26 Turnaround / 2026-04-29 Research
  • [Research] SK hynix (000660 / SKHY) – Eugene Investment | AI Infrastructure · Memory Shortage · Product Mix / 2026-07-31 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme